Please use this identifier to cite or link to this item: https://doi.org/10.1208/s12249-010-9435-7
Title: Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol
Authors: Das, S.
Ng, K.-Y. 
Ho, P.C. 
Keywords: Bead
Delayed release
Formulation parameters
Resveratrol
Zn-pectinate
Issue Date: Jun-2010
Citation: Das, S., Ng, K.-Y., Ho, P.C. (2010-06). Formulation and optimization of zinc-pectinate beads for the controlled delivery of resveratrol. AAPS PharmSciTech 11 (2) : 729-742. ScholarBank@NUS Repository. https://doi.org/10.1208/s12249-010-9435-7
Abstract: Preventive and therapeutic efficacies of resveratrol on several lower gastrointestinal (GI) diseases (e.g., colorectal cancer, colitis) are well documented. To overcome the problems due to its rapid absorption and metabolism at the upper GI tract, a delayed release formulation of resveratrol was designed to treat these lower GI diseases. The current study aimed to develop a delayed release formulation of resveratrol as multiparticulate pectinate beads by varying different formulation parameters. Zinc-pectinate (Zn-pectinate) beads exhibited better delayed drug release pattern than calcium-pectinate (Ca-pectinate) beads. The effects of the formulation parameters were investigated on shape, size, Zn content, moisture content, drug encapsulation efficiency, swelling-erosion, and resveratrol retention pattern of the formulated beads. Upon optimization of the formulation parameters in relative to the drug release profiles, the optimized beads were further subjected to morphological, chemical interaction, enzymatic degradation, and stability studies. Almost all prepared beads were spherical with ∼1 mm diameter and efficiently encapsulated resveratrol. The formulation parameters revealed great influence on resveratrol retention and swelling-erosion behavior. In most of the cases, the drug release data more appropriately fitted with zero-order equation. This study demonstrates that the optimized Znpectinate beads can encapsulate very high amount of resveratrol and can be used as delayed release formulation of resveratrol. © 2010 American Association of Pharmaceutical Scientists.
Source Title: AAPS PharmSciTech
URI: http://scholarbank.nus.edu.sg/handle/10635/105963
ISSN: 15309932
DOI: 10.1208/s12249-010-9435-7
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

43
checked on Nov 14, 2018

WEB OF SCIENCETM
Citations

37
checked on Nov 6, 2018

Page view(s)

40
checked on Nov 9, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.